Efficacy and safety of angiotensin receptor-neprilysin inhibition in heart failure patients with end-stage kidney disease on maintenance dialysis: A systematic review and meta-analysis.
Nguyen Viet DungThanh Ngoc LeBinh Quang TruongNguyen Thi Thu HoaiPublished in: European journal of heart failure (2024)
This meta-analysis provided insights into the benefits of ARNI in HF patients with ESKD undergoing dialysis by improving left ventricular function, reversing left ventricular remodelling, and reducing the risk of all-cause mortality, without increasing the risk of HF hospitalizations, severe hyperkalaemia, and symptomatic hypotension.
Keyphrases
- left ventricular
- heart failure
- acute heart failure
- chronic kidney disease
- systematic review
- cardiac resynchronization therapy
- end stage renal disease
- hypertrophic cardiomyopathy
- acute myocardial infarction
- aortic stenosis
- left atrial
- mitral valve
- peritoneal dialysis
- meta analyses
- angiotensin ii
- early onset
- angiotensin converting enzyme
- randomized controlled trial
- aortic valve
- binding protein
- ejection fraction